lysine has been researched along with Diabetic Neuropathies in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, W; Jiao, Y; Li, Q; Li, YZ; Xie, KL; Yu, Y; Yu, YH; Zhang, YH | 1 |
| Aubert, CE; Bourron, O; Fonfrede, M; Gillery, P; Hartemann, A; Jaisson, S; Michel, PL; Morel, F | 1 |
| Babizhayev, MA; Lankin, VZ; Nosikov, VV; Savel'yeva, EL; Sitnikov, VF; Strokov, IA; Yegorov, YE | 1 |
| Bujalska-Zadrożny, M; de Cordé, A; Pawlik, K | 1 |
| Bujalska, M; Makulska-Nowak, H | 1 |
| Cottin, Y; Ghibu, S; Richard, C; Rochette, L; Vergely, C; Zeller, M | 1 |
| Bierhaus, A; Haslbeck, KM; Haslbeck, M; Heuss, D; Nawroth, P; Neundörfer, B; Schleicher, E | 1 |
| Contreras, I; Giansante, E; Gonzalez-Mujica, F; Lopez, T; Martinez, N; Molina, M; Postalian, S; Reiser, KM; Sanchez, MR; Suarez, N | 1 |
| Monnier, V | 1 |
| Brandt, R; Hanschke, R; Hartmann, K; Hehmke, B; Jäger, B; Kasbohm, J; Krantz, S; Landmesser, C; Michaelis, D; Vogt, L | 1 |
| Blanco, MC; Camejo, M; Contreras, I; Giansante, E; Gonzalez, F; Lopez, T; Martinez, N; Molina, M; Postalian, S; Reiser, KM; Sanchez, MR; Suarez, N | 1 |
| Hamada, Y; Horiuchi, S; Hotta, N; Kasuya, Y; Kato, K; Komori, T; Nagai, R; Nakamura, J; Naruse, K | 1 |
| Schmidt, AM; Stern, DM; Yan, SD; Yan, SF | 1 |
| Fedele, D; Lapolla, A; Traldi, P | 1 |
| Friess, U; Haslbeck, KM; Heuss, D; Kirchner, A; Neundörfer, B; Schleicher, ED | 1 |
| Baba, S; Hata, F; Igaki, N; Maeda, Y; Masuta, S; Nakamichi, T; Ohara, T; Oimomi, M; Sakai, M | 1 |
| Baba, S; Hata, F; Hatanaka, H; Kitamura, Y; Maeda, Y; Matsumoto, S; Nishimoto, S; Oimomi, M | 1 |
4 review(s) available for lysine and Diabetic Neuropathies
| Article | Year |
|---|---|
Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Diabetic Neuropathies; Dietary Supplements; Endothelium, Vascular; Humans; Lysine; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Molecular Structure; Reactive Oxygen Species; Thioctic Acid | 2009 |
[Non-enzymatic glycosylation of proteins. Complications of diabetes mellitus, aging and kidney failure].
Topics: Aging; Arginine; Blood Glucose; Diabetes Mellitus; Diabetic Neuropathies; Glycation End Products, Advanced; Glycosylation; Guanidines; Humans; Lysine; Maillard Reaction; Renal Insufficiency | 1993 |
The biology of the receptor for advanced glycation end products and its ligands.
Topics: Amyloidosis; Animals; Capillary Permeability; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Endothelium, Vascular; Erythrocytes; Glycation End Products, Advanced; Humans; Ligands; Lung; Lysine; Membrane Proteins; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serum Amyloid A Protein; Tumor Cells, Cultured | 2000 |
AGE in micro- and macroangiopathy.
Topics: Aging; Animals; Arginine; Arteriosclerosis; Cell Adhesion; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Interferon-gamma; Lysine; Membrane Proteins; Microcirculation; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; T-Lymphocytes; Vascular Diseases | 2001 |
1 trial(s) available for lysine and Diabetic Neuropathies
| Article | Year |
|---|---|
Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM.
Topics: Analysis of Variance; Arginine; Aspirin; Biopsy; Blood Glucose; Collagen; Cross-Linking Reagents; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Double-Blind Method; Glycated Hemoglobin; Lysine; Placebos; Skin | 1997 |
12 other study(ies) available for lysine and Diabetic Neuropathies
| Article | Year |
|---|---|
Lysine demethylase KDM5B down-regulates SIRT3-mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus; Diabetic Neuropathies; Glucose; Jumonji Domain-Containing Histone Demethylases; Lipid Metabolism; Lysine; Mice; Nuclear Proteins; Reactive Oxygen Species; Repressor Proteins; Sirtuin 3 | 2023 |
Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
Topics: Aged; Arterial Occlusive Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Paris; Peripheral Nervous System; Prevalence; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors; Severity of Illness Index; Sex Factors; Solubility; Waist Circumference | 2014 |
The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patient
Topics: Adult; Antioxidants; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Genetic Predisposition to Disease; Glycation End Products, Advanced; Humans; Lysine; Male; Oxidative Stress; Polymorphism, Genetic; Reactive Oxygen Species; Superoxides; Young Adult | 2015 |
Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy.
Topics: Animals; Arachidonic Acids; Cannabinoids; Celecoxib; Cyclooxygenase Inhibitors; Diabetic Neuropathies; Drug Synergism; Hyperalgesia; Indazoles; Lysine; Male; Neuralgia; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Pain Measurement; Rats; Rats, Wistar; Streptozocin | 2015 |
Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Evaluation, Preclinical; Enzyme Inhibitors; Hyperalgesia; Hypoglycemic Agents; Indazoles; Lysine; Male; Nitric Oxide Synthase; Nitroarginine; Pain Measurement; Rats; Rats, Wistar; Receptors, Bradykinin; Streptozocin; Tetrahydroisoquinolines; Vincristine | 2009 |
The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).
Topics: Aged; Biopsy; Charcot-Marie-Tooth Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glucose Intolerance; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; NF-kappa B; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sural Nerve | 2005 |
Pentosidine content in skin collagen from type II diabetic patients.
Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dipeptides; Humans; Lysine; Middle Aged; Reference Values; Skin | 1994 |
Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance.
Topics: Adult; Age of Onset; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructosamine; Glycated Hemoglobin; Humans; Lysine; Macrophages; Male; Membrane Proteins; Middle Aged; Monocytes; Nuclear Proteins; Probability; Rats; Rats, Inbred BB; Reference Values; RNA-Binding Proteins | 1996 |
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines | 2000 |
N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
Topics: Adult; Aged; Biopsy; Blotting, Western; Charcot-Marie-Tooth Disease; Diabetic Neuropathies; Female; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Oxidative Stress; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sural Nerve | 2002 |
Clinical application of hair protein glycation in the assessment of blood glucose control and diabetic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Glycated Hemoglobin; Glycoproteins; Hair; Humans; Lysine; Male; Middle Aged; Neural Conduction | 1989 |
Glycosylation levels of nail proteins in diabetic patients with retinopathy and neuropathy.
Topics: Adult; Aged; Diabetes Mellitus; Diabetic Neuropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Nails | 1985 |